Includes cutting-edge methods and protocols

Provides step-by-step detail essential for reproducible results

Contains key notes and implementation advice from the experts

Identification and enumeration of Plasmodium falciparum parasites by light microscopy.- Collection and cryopreservation of Plasmodium falciparum clinical isolates in the field.- Preservation of parasite RNA in the field.- Preservation and extraction of malaria parasite DNA from dried blood spots.- Establishing and maintaining in vitro cultures of asexual blood stages of Plasmodium falciparum.- Genotyping of Plasmodium falciparum isolates to assess clone composition in parasite cultures.- Immunomagnetic selection of Plasmodium falciparum-infected erythrocytes expressing particular PfEMP1 variants.- Single-cell sorting of Plasmodium falciparum-infected erythrocytes expressing particular PfEMP1 variants.- Selecting Plasmodium falciparum infected erythrocytes for adhesion to cell lines.- Synchronisation of Plasmodium falciparum and P. knowlesi in vitro cultures using a highly specific protein kinase inhibitor.- Generation of Plasmodium falciparum gametocytes in vitro with specific considerations for field isolates.- Imaging of extracellular vesicles derived from Plasmodium falciparum-infected red blood cells using atomic force microscopy.- Analysis of var gene transcript patterns by quantitative real-time PCR.- Analysis of var gene transcription pattern using DBL¿-tags.- RNAseq of infected erythrocyte surface antigen-encoding genes.- Resetting var gene transcription in Plasmodium falciparum.- CRISPR/Cas9 editing of the Plasmodium falciparum genome.- CRISPR-Cas9 editing of the Plasmodium falciparum genome - Special applications.- Extraction and immunoprecipitation of VAR2CSA, the PfEMP1 associated with placental malaria.- Expression of single-domain soluble and disulfide-folded PfEMP1 antigens in the Escherichia coli SHuffle expression system.- Expression of large full-length PfEMP1 proteins in HEK293 cells.- Receptor affinity-based purification of PfEMP1 proteins.- Analysis of antibody reactivity to malaria antigens by microsphere-based multiplex immunoassay.- High-throughput BioPlex assay for the study of functionally active Plasmodium falciparum antigens that are expressed on the surface of infected erythrocytes.- Protein microarrays as a tool to analyze antibody responses to variant surface antigens expressed on the surface of Plasmodium falciparum-infected erythrocytes.- Protocol for differential biopanning of Plasmodium falciparum phage display cDNA library to identify parasite targets of protective antibodies.- Affinity purification of PfEMP1-specific antibodies from human blood.- Production of anti-PfEMP1 polyclonal antisera in rats and mice.- Production of PfEMP1-specific mouse monoclonal antibodie.- Production of PfEMP1-specific human monoclonal antibodies from naturally immune individuals.- Visualization of infected red blood cell surface antigens by fluorescence microscop.- Analysis by flow cytometry of ¿2¿macroglobulin and non-immune IgM-binding to Plasmodium falciparum-infected erythrocytes.- An improved method for assessing antigen presentation on the surface of Plasmodium falciparum-infected erythrocytes by immuno-electron microscopy.- Assessing antigen presentation on the surface of Plasmodium falciparum-infected erythrocytes by photoactivated localization microscopy (PALM).- Surface plasmon resonance analysis of PfEMP1 interaction with receptors.- Analysis of antibody neutralization of PfEMP1 binding by competition ELISA.- Measuring rosetting inhibition in Plasmodium falciparum parasites using a flow cytometry-based assay.- Bridging and clumping: investigating platelet interactions with Plasmodium falciparum-infected red blood cells and endothelial cells in cerebral malaria.- Assay of static adhesion of Plasmodium falciparum-infected erythrocytes to cells, including inhibition of the adhesion.- Static adhesion of Plasmodium falciparum-infected erythrocytes to purified and recombinant receptors.- Selecting Plasmodium falciparum-infected erythrocytes for adhesion to recombinant receptors under flow conditions.- Chip-based assay of adhesion of Plasmodium falciparum-infected erythrocytes to cells under flow.- Binding of Plasmodium falciparum-infected red blood cells to engineered 3D microvessels.- 3D organoid assay of the impact of Plasmodium falciparum-infected erythrocyte adhesion on the blood-brain barrier.- Receptor-functionalized lipid membranes as biomimetic surfaces for adhesion of Plasmodium falciparum-infected erythrocytes.- Antibody-dependent THP-1 cell-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes.- Assaying interactions between neutrophils and Plasmodium falciparum-infected red blood cells.- Natural killer cell antibody dependent cellular cytotoxicity (ADCC) activity against Plasmodium falciparum-infected red blood cells.- Assessing PfGARP-mediated apoptosis of blood-stage Plasmodium falciparum parasites.- Enzyme-linked immunosorbent assay for activation of the classical complement pathway by Plasmodium falciparum-infected erythrocyte surface antigen-specific antibodies.- Flow cytometry assay of Plasmodium falciparum-specific B-cell proportions.- Assessment of Plasmodium falciparum antigen-specific B cells.- Whole blood dendritic cell cytokine production assay.- Measuring the impact of malaria on the living human retina.- Ocular pathology of cerebral malaria.- Investigating interactions between endothelial cells and parasitised red blood cells in skin and subcutaneous tissue.